{"id":"chloroprocaine-3","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient paresthesia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Back pain"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Allergic reactions (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an ester-type local anesthetic, chloroprocaine reversibly inhibits sodium influx through voltage-gated sodium channels in nerve fibers, thereby preventing depolarization and action potential generation. This results in loss of sensation in the infiltrated tissue. Chloroprocaine is rapidly metabolized by plasma pseudocholinesterase, giving it a short duration of action.","oneSentence":"Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:44:59.997Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Local anesthesia for infiltration, nerve block, and epidural anesthesia"}]},"trialDetails":[{"nctId":"NCT05926258","phase":"PHASE3","title":"Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2024-05-23","conditions":"Local Anesthetic","enrollment":74},{"nctId":"NCT07456826","phase":"PHASE4","title":"Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections","status":"NOT_YET_RECRUITING","sponsor":"Harrow Inc","startDate":"2026-04","conditions":"Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion","enrollment":236},{"nctId":"NCT05934253","phase":"PHASE4","title":"The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine","status":"COMPLETED","sponsor":"Harrow Inc","startDate":"2023-07-15","conditions":"Antiseptic, Anesthesia, Local","enrollment":100},{"nctId":"NCT03760718","phase":"EARLY_PHASE1","title":"Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2019-09-30","conditions":"Cesarean Section","enrollment":15},{"nctId":"NCT02919072","phase":"PHASE3","title":"Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section","status":"TERMINATED","sponsor":"Sintetica SA","startDate":"2016-10","conditions":"Unplanned Caesarean Section","enrollment":16},{"nctId":"NCT01719237","phase":"PHASE4","title":"Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2009-08","conditions":"Pain","enrollment":60},{"nctId":"NCT04685538","phase":"PHASE3","title":"Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2020-09-09","conditions":"Cataract","enrollment":338},{"nctId":"NCT04369950","phase":"PHASE4","title":"Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-05-11","conditions":"Physiological Effect of Drugs, Morphine, Analgesics","enrollment":44},{"nctId":"NCT04753710","phase":"PHASE2, PHASE3","title":"Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2020-06-29","conditions":"Healthy Volunteers","enrollment":96},{"nctId":"NCT03805438","phase":"PHASE4","title":"ED90 of 3% Chloroprocaine for Cervical Cerclage","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-02-07","conditions":"Cerclage, Cervical","enrollment":47},{"nctId":"NCT04779606","phase":"PHASE1, PHASE2","title":"Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2020-06-16","conditions":"Healthy Subjects","enrollment":105},{"nctId":"NCT03428230","phase":"PHASE2","title":"Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2018-08-06","conditions":"Pain, Postoperative","enrollment":60},{"nctId":"NCT02481505","phase":"PHASE2","title":"Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.","status":"COMPLETED","sponsor":"Sintetica SA","startDate":"2015-06","conditions":"Short Duration Lower Limb Surgery Via Spinal Anaesthesia","enrollment":45},{"nctId":"NCT02862912","phase":"PHASE4","title":"Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)","status":"COMPLETED","sponsor":"Columbia University","startDate":"2016-11-08","conditions":"Adverse Reaction to Spinal Anesthetic, Maternal Care for Cervical Incompetence","enrollment":43},{"nctId":"NCT03305575","phase":"PHASE4","title":"Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2017-10-13","conditions":"Cervical Incompetence","enrollment":10},{"nctId":"NCT03414359","phase":"EARLY_PHASE1","title":"Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2018-02-15","conditions":"Surgical Anesthesia, Cesarean Section","enrollment":70},{"nctId":"NCT02406703","phase":"","title":"The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs","status":"COMPLETED","sponsor":"Ospedale Regionale Bellinzona e Valli","startDate":"2014-01","conditions":"Impact of Anesthetic Choice on Costs","enrollment":100},{"nctId":"NCT03882489","phase":"","title":"Estimation of Effective Dose 95 (ED95) of Intrathecal Isobaric 2-chloroprocaine (2-CP) Based on the Height (cm) of a Patient Undergoing Ambulatory Knee Arthroscopy","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Saint Pierre","startDate":"2019-04-11","conditions":"Knee Arthroscopy","enrollment":120},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435},{"nctId":"NCT03805503","phase":"PHASE4","title":"Chloroprocaine for Inguinal Herniorrhaphy","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2015-09-16","conditions":"Spinal Anesthesia","enrollment":12},{"nctId":"NCT02287870","phase":"PHASE4","title":"Epidural Anesthesia With Chloroprocaine Versus Lidocaine","status":"COMPLETED","sponsor":"Jinling Hospital, China","startDate":"2008-01","conditions":"Anesthesia","enrollment":120},{"nctId":"NCT00487084","phase":"NA","title":"Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2004-08","conditions":"Labor, Analgesia, Epidural","enrollment":136},{"nctId":"NCT01655277","phase":"PHASE4","title":"Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block for Quadriceps Strength and Fall-risk","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2012-02","conditions":"Quadriceps Muscle Weakness, Adductor Muscle Weakness, Fall Risk","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Arm 1"],"phase":"phase_3","status":"active","brandName":"Chloroprocaine 3%","genericName":"Chloroprocaine 3%","companyName":"Sintetica SA","companyId":"sintetica-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. Used for Local anesthesia for infiltration, nerve block, and epidural anesthesia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}